A detailed history of Israel Englander (Millennium Management LLC) transactions in Opti Nose, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 629,121 shares of OPTN stock, worth $239,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares
629,121
Previous 1,075,640 41.51%
Holding current value
$239,065
Previous $1.12 Million 62.34%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.67 - $1.27 $299,167 - $567,079
-446,519 Reduced 41.51%
629,121 $421,000
Q2 2024

Aug 14, 2024

BUY
$0.82 - $1.44 $610,862 - $1.07 Million
744,954 Added 225.28%
1,075,640 $1.12 Million
Q1 2024

May 15, 2024

BUY
$1.17 - $1.94 $249,091 - $413,024
212,899 Added 180.75%
330,686 $482,000
Q4 2023

Feb 14, 2024

SELL
$1.02 - $1.47 $514,412 - $741,359
-504,326 Reduced 81.07%
117,787 $151,000
Q2 2023

Aug 14, 2023

BUY
$1.11 - $2.05 $307,946 - $568,729
277,429 Added 80.49%
622,113 $765,000
Q1 2023

May 15, 2023

BUY
$1.63 - $2.02 $541,342 - $670,866
332,112 Added 2641.68%
344,684 $665,000
Q4 2022

Feb 14, 2023

SELL
$1.68 - $3.7 $269,545 - $593,642
-160,444 Reduced 92.73%
12,572 $23,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $4.01 $39,633 - $46,335
-11,555 Reduced 6.26%
173,016 $633,000
Q2 2022

Aug 15, 2022

SELL
$1.76 - $3.82 $392,047 - $850,920
-222,754 Reduced 54.69%
184,571 $676,000
Q1 2022

May 16, 2022

BUY
$1.77 - $2.93 $75,587 - $125,125
42,705 Added 11.71%
407,325 $1.01 Million
Q4 2021

Feb 14, 2022

SELL
$1.55 - $3.1 $2,734 - $5,468
-1,764 Reduced 0.48%
364,620 $591,000
Q3 2021

Nov 15, 2021

SELL
$2.35 - $3.16 $759,912 - $1.02 Million
-323,367 Reduced 46.88%
366,384 $1.1 Million
Q2 2021

Aug 16, 2021

BUY
$2.91 - $3.83 $1.81 Million - $2.39 Million
623,403 Added 939.6%
689,751 $2.15 Million
Q1 2021

May 17, 2021

SELL
$3.47 - $4.75 $710,347 - $972,377
-204,711 Reduced 75.52%
66,348 $245,000
Q4 2020

Feb 16, 2021

BUY
$3.2 - $4.98 $107,987 - $168,055
33,746 Added 14.22%
271,059 $1.12 Million
Q3 2020

Nov 16, 2020

BUY
$3.69 - $7.09 $875,684 - $1.68 Million
237,313 New
237,313 $926,000
Q2 2020

Aug 14, 2020

SELL
$3.58 - $7.44 $261,325 - $543,090
-72,996 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$3.49 - $9.2 $792,010 - $2.09 Million
-226,937 Reduced 75.66%
72,996 $328,000
Q4 2019

Feb 14, 2020

BUY
$6.27 - $11.41 $1.41 Million - $2.56 Million
224,186 Added 295.97%
299,933 $2.77 Million
Q3 2019

Nov 14, 2019

BUY
$4.75 - $8.38 $211,945 - $373,915
44,620 Added 143.35%
75,747 $530,000
Q2 2019

Aug 14, 2019

BUY
$6.4 - $10.94 $199,212 - $340,529
31,127 New
31,127 $220,000
Q1 2019

May 14, 2019

SELL
$6.1 - $10.3 $301,931 - $509,819
-49,497 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$5.84 - $11.92 $335,671 - $685,137
-57,478 Reduced 53.73%
49,497 $307,000
Q3 2018

Nov 14, 2018

BUY
$12.43 - $29.76 $1.14 Million - $2.73 Million
91,711 Added 600.83%
106,975 $1.33 Million
Q2 2018

Aug 14, 2018

BUY
$18.75 - $28.46 $286,200 - $434,413
15,264 New
15,264 $427,000
Q1 2018

May 15, 2018

SELL
$15.91 - $20.82 $159,625 - $208,887
-10,033 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$15.2 - $20.76 $152,501 - $208,285
10,033
10,033 $190,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $31.6M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.